Pharmafile Logo

Medscape Oncology Launches Inaugural Medscape Fellows Program at ASCO 2024

- PMLiVE

Medscape Oncology is excited to announce the launch of the first-ever Medscape Fellows Program at the 2024 ASCO meeting in Chicago, Illinois. This groundbreaking program aims to nurture young oncology talent and advance outcomes through education.

“Today’s fellows represent the future of oncology. Our Medscape Oncology Fellows are poised to become leaders in cancer care, and we wanted to bring them together at oncology’s biggest event in the United States to show them the impact they can make. We’re looking forward to a weekend full of events and programs for them,” said Natasha McGrath, Executive Director, Medscape Education.

The Medscape Fellows Program will kick off with a welcome reception and feature a series of events throughout the weekend designed to inspire, educate, and connect fellows with leading experts in the field. By engaging in workshops, networking opportunities, symposia, and focus group sessions, fellows will gain valuable insights and skills to advance their careers and improve patient outcomes.

Medscape will also use insights from this program to help build new tools and programs designed to engage and elevate both fellows and young faculty. By placing education at the forefront, Medscape aims to advance clinical practice and improve patient outcomes.

For more information on the Medscape Fellows Program, please contact Natasha McGrath at NMcGrath@Medscape.net.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Medscape Education Receives Joint Accreditation with Commendation to Deliver Continuing Education for Healthcare Providers

Medscape Education has been awarded Accreditation with Commendation, the highest designation possible by the Joint Accreditation for Interprofessional Continuing Education™, ensuring quality accredited continuing education for members of the healthcare...

Abstract Highlights from EHA 2022 : A Spotlight on CLL

Spotlight on CLLAhead of EHA 2022, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, caught up with Prof John Gribben, UK, on the most important abstracts to look out for in...

Abstract Highlights from EHA 2022 : A Spotlight on Lymphoma

Spotlight on LymphomaAhead of EHA 2022, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, caught up with Dr Loretta Nastoupil, US, on the most important abstracts to look out for in...

TECHNOLOGY TRENDS AND THE FUTURE OF MEDICAL DEVICES

A MEDSCAPE DIGITAL HEALTH AND INNOVATION EVENT

Device Technology and Innovations

The world of medical device technology is constantly evolving. From wearable devices to diagnostic technology, clinicians have more options than ever for monitoring and assessing their patients' health. The accessibility...

The Power of AI in Medical Education

Artificial intelligence (AI) is a rapidly growing field with many applications in the world of medicine, including continuing medical education. Ritu Kumar, Medscape lead data scientist, explains how Medscape Education...

Connect to the conversation around mental health: A spotlight on physician burnout

For more than 2 years, the COVID-19 pandemic has put emphasis on an issue that has long affected healthcare workers and physicians -- burnout. Every year, Medscape surveys thousands of...

MEDSCAPE EDUCATION: The Human Story in Virtual Patient Simulation

WHAT'S THE STORYStories are shared experiences, where meaning-centered approaches and coping strategies ascribe cultural meaningto events and emotions; a way to merge the individual and the collective experience into the...

It’s a Medscape wrap for EHA2022

EHA2022 Hybrid Congress has now come to a close with the Thematic Days finishing last week. The Medscape team were delighted to connect with so many physicians, colleagues and supporters...

Part 4 of 4, of the Medscape video interview series

Dr. Hansa Bhargava MD interviews Dr. Maria Victoria Mateos on the most important abstracts to look out for in multiple myeloma and the potential implications of these data for managing patients...